The mechanism of action of GSK-3 is however complex and context-dependent, since its overexpression in some cell types inhibits AR [10, 11] and there are instances where GSK-3 inhibitors reduce proliferation of AR-negative PCa cells [13, 14]. This evidence concerns the gene AR and posterior cortical atrophy.